Brain Tumor Pathology

Papers
(The median citation count of Brain Tumor Pathology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles34
The molecular framework of pediatric-type diffuse gliomas: shifting toward the revision of the WHO classification of tumors of the central nervous system22
Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L120
EZH2 inhibitory protein (EZHIP/Cxorf67) expression correlates strongly with H3K27me3 loss in posterior fossa ependymomas and is mutually exclusive with H3K27M mutations20
Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis17
Molecular subtyping of ependymoma and prognostic impact of Ki-6713
Spinal cord astroblastoma with EWSR1-BEND2 fusion classified as HGNET-MN1 by methylation classification: a case report12
Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features12
Implications of immune cells in oncolytic herpes simplex virotherapy for glioma11
The proteomic analysis shows enrichment of RNA surveillance pathways in adult SHH and extensive metabolic reprogramming in Group 3 medulloblastomas11
Droplet digital PCR assay for detecting TERT promoter mutations in patients with glioma11
Epithelioid inflammatory myofibroblastic sarcoma with VCL–ALK fusion of central nervous system: case report and brief review of the literature10
Predicting BRAF V600E mutation in glioblastoma: utility of radiographic features10
Prognostic significance of TERT promoter mutations in adult-type diffuse gliomas10
Anti-angiogenic and macrophage-based therapeutic strategies for glioma immunotherapy9
Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options9
T2-fluid-attenuated inversion recovery mismatch sign in lower grade gliomas: correlation with pathological and molecular findings9
Primary central nervous system lymphoma: clinicopathological and genomic insights for therapeutic development8
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype: case series of a new entity8
A novel YAP1-MAML2 fusion in an adult supra-tentorial ependymoma, YAP1-fused8
Intracranial angiomatoid fibrous histiocytoma with rhabdoid features: a mimic of rhabdoid meningioma8
Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas8
Update of the 2021 WHO classification of tumors of the central nervous system: adult diffuse gliomas7
Aggressive nonfunctioning pituitary neuroendocrine tumors7
Liquid biomarkers in glioma7
IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis7
Diffusely infiltrating glioma with CREBBP–BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report7
Clinical implications of molecular analysis in diffuse glioma stratification7
Histopathological predictors of progression-free survival in atypical meningioma: a single-center retrospective cohort and meta-analysis6
Ribosomal proteins induce stem cell-like characteristics in glioma cells as an “extra-ribosomal function”6
Clinicopathologic significance of MYD88 L265P mutation and expression of TLR4 and P-STAT3 in primary central nervous system diffuse large B-cell lymphomas6
A patient with two gliomas with independent oligodendroglioma and glioblastoma biology proved by DNA-methylation profiling: a case report and review of the literature5
Multi-omics analysis of intertumoral heterogeneity within medulloblastoma uncharted-pathway subtypes5
Masked malignant phenotype with a benign appearance: beat-up copy number profile may be the key for hemangioblastoma dissemination5
Genetic characterization of an aggressive optic nerve pilocytic glioma5
Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma5
Emerging glioneuronal and neuronal tumors: case-based review5
High-grade neuroepithelial tumor with EP300::BCOR fusion and negative BCOR immunohistochemical expression: a case report4
Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms4
Molecular subgrouping of ependymoma across three anatomic sites and their prognostic implications4
Revisiting vimentin: a negative surrogate marker of molecularly defined oligodendroglioma in adult type diffuse glioma4
Clinicopathological risk factors for a poor prognosis of primary central nervous system lymphoma in elderly patients in the Tohoku and Niigata area: a multicenter, retrospective, cohort study of the T4
Clinical and radiological findings of glioblastomas harboring a BRAF V600E mutation4
Metabolic, immunohistochemical, and genetic profiling of a cerebellar liponeurocytoma with spinal dissemination: a case report and review of the literature4
Loss of H3K27me3 in WHO grade 3 meningioma4
Association between IDH mutational status and tumor-associated epilepsy or venous thromboembolism in patients with grade II and III astrocytoma3
Timing of H3K27me3 loss in secondary anaplastic meningiomas3
Unique pathological findings of astroblastoma with MN1 alteration in a patient with late recurrence3
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors3
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement3
Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas3
Whole-genome sequencing analysis of an atypical teratoid/rhabdoid tumor in a patient with Phelan–McDermid syndrome: a case report and systematic review3
Role of proliferative marker index and KBTBD4 mutation in the pathological diagnosis of pineal parenchymal tumors3
Preface for Brain Tumor Pathology vol. 39 issue 22
Immunohistochemical and ultrastructural review of six cases previously diagnosed as null cell PitNETs2
The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas2
Clinical characteristics and radiological features of glioblastoma, IDH-wildtype, grade 4 with histologically lower-grade gliomas2
A case of a rosette-forming glioneuronal tumor with clinicopathological features of a dysembryoplastic neuroepithelial tumor and fibroblast growth factor receptor 1 internal tandem duplication2
Morphologically, genetically and spatially mixed astrocytoma and oligodendroglioma; chronological acquisition of 1p/19q codeletion and CDKN2A deletion: a case report2
Concomitant KIAA1549-BRAF fusion and IDH mutation in Pediatric spinal cord astrocytoma: a case report and literature review2
Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature2
Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas2
A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment2
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment2
A rare case of primary central nervous system histiocytic sarcoma harboring a novel ARHGAP45::BRAF fusion: a case report and literature review2
0.16268086433411